Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
Healthtrust
Chinese Patent Office
McKesson
Deloitte
McKinsey
Baxter
Federal Trade Commission

Generated: May 20, 2018

DrugPatentWatch Database Preview

INOCOR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Inocor patents expire, and what generic alternatives are available?

Inocor is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in INOCOR is inamrinone lactate. There is one drug master file entry for this compound. Additional details are available on the inamrinone lactate profile page.
Drug patent expirations by year for INOCOR
Synonyms for INOCOR
(3,4'-BIPYRIDIN)-6(1H)-ONE, 5-AMINO-
(3,4'-Bipyridin)-6(1H)-one, 5-amino-, 3-hydroxypropanoate
[3,4'-Bipyridin]-6(1H)-one, 5-amino-
3-Amino-5-(4-pyridinyl)-1,2-dihydro-2-pyridone
3-Amino-5-(4-pyridinyl)-2(1H)-pyridinone
3-Amino-5-(4-pyridinyl)-2(1H)pyridinone
3-amino-5-(4-pyridyl)-1H-pyridin-2-one
3-amino-5-(4-pyridyl)hydropyridin-2-one
3-amino-5-(pyridin-4-yl)-1,2-dihydropyridin-2-one
3-amino-5-(pyridin-4-yl)pyridin-2-ol
3-amino-5-pyridin-4-yl-1H-pyridin-2-one
3-amino-5-pyridin-4-yl-1H-pyridin-2-one; 2-hydroxypropanoic acid
3-azanyl-5-pyridin-4-yl-1H-pyridin-2-one
3-Hydroxypropanoic acid compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one
3-hydroxypropanoicacid
5-25-15-00181 (Beilstein Handbook Reference)
5-Amino-(3,4?-bipyridin)-6(1H)-one
5-Amino-(3,4'-bipyridin)-6(1H)-one
5-Amino-(3,4'-bipyridin)-6(1H)-one; Inocor
5-Amino-(3,4'-bipyridine)-6(1H)-one
5-Amino-[3,4'-bipyridin]-6(1H)-one
5-amino-3,4'-bipyridin-6-ol
5-amino-3,4'-bipyridin-6(1H)-one
5-Amino(3,4'-bipyridin)-6(1H)-one
5-Amino(3,4'-bipyridine)-6-(1H)-one
5-Amino[3,4'-bipyridin]-6(1H)-one
60719-84-8
719A848
75898-90-7
A832852
AB00052312_05
AB00052312-04
AC-12186
AC1L1GIK
AC1MHYWP
AJ-57896
AK-99994
AKOS005512516
Amcoral
Amcoral (TN)
Amrinon
Amrinona
Amrinona [INN-Spanish]
Amrinone
Amrinone (JAN/INN)
Amrinone lactate
Amrinone, United States Pharmacopeia (USP) Reference Standard
Amrinonum
Amrinonum [INN-Latin]
AN-39455
ANW-56874
API0001483
AWD 08-250
AX8012830
BDBM34651
BG0040
Bio-0795
BPBio1_001034
BRD-K45924332-001-04-4
BRN 0744819
BSPBio_000940
C-07649
C10H9N3O
Cartonic
CAS-60719-84-8
CC-24111
CCG-39487
CCRIS 3794
CHEBI:2686
CHEBI:95269
CHEMBL12856
CHEMBL2096642
cid_3698
Cordemcura
CTK8A0862
CTK8B7264
D00231
D0GB0P
D0R6TI
DB01427
DivK1c_000136
DR000256
DSSTox_CID_2603
DSSTox_GSID_22603
DSSTox_RID_76655
DTXSID9022603
EBD25770
EINECS 262-390-0
FCH835239
FT-0601595
GP7331
GTPL7202
HE246408
HE360664
HMS1570O22
HMS2097O22
HMS2234F12
HMS3264E16
HMS3369J10
HMS500G18
I06-0688
I229274Y5B
IDI1_000136
inamrinone
Inamrinone (USP)
Inamrinone [USAN:BAN:INN]
Inamrinone lactate
Inocor (TN)
JUT23379TN
KB-47388
KBio1_000136
KBio2_001830
KBio2_004398
KBio2_006966
KBio3_002052
KBioGR_001398
KBioSS_001830
KS-00000G6B
KS-5178
LS-121477
LS-44658
M-2461
MCULE-2781267039
MLS000069829
MLS001074083
MolPort-002-652-742
MolPort-006-132-085
NCGC00016896-01
NCGC00016896-02
NCGC00016896-03
NCGC00016896-06
NCGC00095984-01
NCGC00164379-01
NCGC00255137-01
NINDS_000136
NSC-759805
NSC759805
Opera_ID_1054
Pharmakon1600-01503084
Prestwick_44
Prestwick0_000800
Prestwick1_000800
Prestwick2_000800
Prestwick3_000800
Propanoic acid, 3-hydroxy-, compd. with 5-amino-(3,4'-bipyridin)-6(1H)-one
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
SC-11925
SCHEMBL13457017
SCHEMBL44012
SCHEMBL739746
SMR000058850
SPBio_002139
SPBio_002879
Spectrum_001350
SPECTRUM1503084
Spectrum2_001980
Spectrum3_000956
Spectrum4_001069
Spectrum5_000999
SR-00000002445
SR-00000002445-2
ST51014892
STK590307
Tox21_112110
Tox21_112110_1
Tox21_301847
UNII-I229274Y5B
UNII-JUT23379TN
Vesistol
W-105234
WIN 40680
Win-40680
Win40680
Wincoram
ZINC8673078

US Patents and Regulatory Information for INOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us INOCOR inamrinone lactate INJECTABLE;INJECTION 018700-001 Jul 31, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
US Army
McKinsey
QuintilesIMS
Cantor Fitzgerald
Citi
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.